Global post‑marketing safety surveillance of Tumor Treating Fields (TTFields) therapy in over 25,000 patients with CNS malignancies treated between 2011-2022 epidem.

By: Mrugala MM, Shi W, Iwomoto F, Lukas RV, Palmer JD, Suh JH, Glas M
Published in: J Neurooncol 2024; 169: 25-38
Download citation in RIS format

Exposure